Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)

CRISPR/CAS-related methods and compositions for treating Leber's Congenital Amaurosis 10 (LCA10)

US Patent 11268086 · Granted Mar 8, 2022

Estimated economic value: $18,875,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crispr/CAS-related methods and compositions for treating primary open angle glau2025
Crispr/CAS-related methods and compositions for treating primary open angle glau2025
CRISPR/Cas9-mediated exon-skipping approach for USH2A-associated usher syndrome2025
Modulation of gene transcription using antisense oligonucleotides targeting regu2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
CRISPR/Cas-related methods and compositions for treating Leber's congenital amau2025
TAL-Tet1 fusion proteins and methods of use thereof2024
Phenothiazine derivatives and uses thereof2024
RNA-guided targeting of genetic and epigenomic regulatory proteins to specific g2024
GNAQ targeted dsRNA compositions and methods for inhibiting expression2024
CRISPR/CAS-related methods and compositions for treating herpes simplex virus2023